Sun Pharma numbers were slightly below expectations in terms of EBITDA and we do think that though they have guided for a very strong growth through their speciality portfolio, that is a little bit time away.
CMR Green Technologies IPO Day 3: Issue booked over 127 times on strong QIB demand; 40% GMP signals strong listing premium
CMR Green Technologies’ IPO saw a strong subscription of 127 times, with QIBs leading the demand. The issue, an offer-for-sale, garnered a grey market premium